The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Arber, Daniel A., Orazi, Attilio, Hasserjian, Robert, Thiele, Jürgen, Borowitz, Michael J., Le Beau, Michelle M., Bloomfield, Clara D., Cazzola, Mario +1 more·2016·Blood

DOI 10.1182/blood-2016-03-643544

Cited by (1,019)

Items 301–400 of 1,019

Chromothripsis in acute myeloid leukemia: biological features and impact on survival
Maria Chiara Fontana, Giovanni Marconi, Jelena D. Milosevic Feenstra, Eugenio Fonzi, Cristina Papayannidis, Andrea Ghelli Luserna di Rorà, Antonella Padella, Vincenza Solli, Eugenia Franchini, Emanuela Ottaviani et al. · 2018 · Leukemia
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia
Ondřej Hrušák, Válerie de Haas, Jitka Stančíková, Barbora Vakrmanová, Iveta Janotová, Ester Mejstříková, Václav Čapek, Jan Trka, Marketa Kubricanova Zaliova, Aleš Lukš et al. · 2018 · Blood
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi · 2018 · American Journal of Hematology
Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support
Mitra Azadniv, Jason R. Myers, Helene R. McMurray, Naxin Guo, Phil Rock, Myra L. Coppage, John M. Ashton, Michael W. Becker, Laura Maria Calvi, Jane L. Liesveld · 2019 · Leukemia
Myelodysplastic syndromes: moving towards personalized management
Eva Hellström‐Lindberg, Magnus Tobiasson, Peter L. Greenberg · 2020 · Haematologica
Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
Mrinal M. Patnaik, Terra L. Lasho, Pooja Vijayvargiya, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Ayalew Tefferi · 2016 · Blood Cancer Journal
Acute Myeloid Leukemia: The Good, the Bad, and the Ugly
Andrew Tucker Kuykendall, Nicolas Duployez, Nicolas Boissel, Jeffrey E. Lancet, John Sutton Welch · 2018 · American Society of Clinical Oncology Educational Book
Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T. Dao, Jason R. Gotlib, Michael W. Deininger, Stephen T. Oh, Jörge E. Cortes, Robert H. Collins, Elliot F. Winton, Dana Parker, Hyunjung Lee, Anna Reister Schultz et al. · 2019 · Journal of Clinical Oncology
A single-cell survey of cellular hierarchy in acute myeloid leukemia
Junqing Wu, Yanyu Xiao, Jie Sun, Huiyu Sun, Haide Chen, Yuanyuan Zhu, Huarui Fu, Chengxuan Yu, E Weigao, Shujing Lai et al. · 2020 · Journal of Hematology & Oncology
High Throughput Blood Analysis Based on Deep Learning Algorithm and Self‐Positioning Super‐Hydrophobic SERS Platform for Non‐Invasive Multi‐Disease Screening
Xueliang Lin, Duo Lin, Yang Chen, Jincheng Lin, Shuyun Weng, Jibin Song, Shangyuan Feng · 2021 · Advanced Functional Materials
Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
Eve Roman, Alex G. Smith, Simon Appleton, Simon Crouch, Richard Kelly, Sally E. Kinsey, Catherine A. Cargo, Russell D. Patmore · 2016 · Cancer Epidemiology
Current status and new treatment approaches in TP53 mutated AML
Hunter, Anthony M., Sallman, David A. · 2019 · Best Practice & Research Clinical Haematology
Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis
Maria Maruffi, Richard Sposto, Matthew James Oberley, Lynn Kysh, Etan Orgel · 2018 · Leukemia
Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL
Yuekun Qi, Mingfeng Zhao, Yongxian Hu, Ying Wang, Ping Li, Jiang Cao, Ming Shi, Jiaqi Tan, Meng Zhang, Xia Xiao et al. · 2022 · Blood
Incidence, Survival, and Risk Factors for Adults with Acute Myeloid Leukemia Not Otherwise Specified and Acute Myeloid Leukemia with Recurrent Genetic Abnormalities: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database, 2001–2013
Xiaolu Song, Peng Ye, Xiaogang Wang, Yirui Chen, Lai Jin, Tianxin Yang, Meihua Qian, Wanmao Ni, Xiangmin Tong, Jianping Lan · 2018 · Acta Haematologica
Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts
Rory Michael Shallis, Rami Ahmad, Amer Methqal Zeidan · 2018 · European Journal Of Haematology
A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA
Konobu Kimura, Yoko Tabe, Tomohiko Ai, Ikki Takehara, Hiroshi Fukuda, Hiromizu Takahashi, Toshio Naito, Norio Komatsu, Kinya Uchihashi, Akimichi Ohsaka · 2019 · Scientific Reports
Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study
Maximilian F. Stahl, Rory Michael Shallis, Wei Wei, Pau Montesinos, Étienne Lengliné, Judith Neukirchen, Vijaya Raj Bhatt, Mikkael Aaron Sekeres, Amir Tahmasb Fathi, Heiko Koenig et al. · 2020 · Leukemia
Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia
Kening Li, Yuxin Du, Yun Cai, Wenjie Liu, Yan Lv, Bin Huang, Lishen Zhang, Zhi Wang, Ping Liu, Qian Sun et al. · 2022 · Leukemia
Karyotype complexity and prognosis in acute myeloid leukemia
Friedrich Stölzel, Brigitte Mohr, Michael Krämer, Uta Oelschlägel, Tilmann Bochtler, Wolfgang E. Berdel, Martin Kaufmann, Claudia Dorothea Baldus, K. Schäfer-Eckart, Reingard Stuhlmann et al. · 2016 · Blood Cancer Journal
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia
Roderick Docking, Jeremy Parker, Martin Jädersten, Gerben Duns, Linda Chang, Jihong Jiang, Jessica A. Pilsworth, Lucas Swanson, Simon K. Chan, Readman Chiu et al. · 2021 · Nature Communications
Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel
Nicola Gökbuget, Nicolas Boissel, Sabina Chiaretti, Hervé Dombret, Michael Doubek, Adele Kay Fielding, Robin Foà, Sebastian Giebel, Dieter F. Hoelzer, Mathilde Hunault et al. · 2024 · Blood
Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia—results of the AMLSG 11-08 trial
Peter Paschka, Richard F. Schlenk, Daniela Weber, Axel Benner, Lars Bullinger, Michael Heuser, Verena I. Gaidzik, Felicitas R. Thol, Mridul Agrawal, Veronica Teleanu et al. · 2018 · Leukemia
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark
Justin Taylor, Michael Haddadin, Vivek A. Upadhyay, Erwin Grussie, Neha Mehta–Shah, Andrew Mark Brunner, Abner Louissaint, Scott B. Lovitch, Ahmet Doǧan, Amir Tahmasb Fathi et al. · 2019 · Blood
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Ryan Michael Carr, Denis Vorobyev, Terra L. Lasho, David L. Marks, Ezequiel J. Tolosa, Alexis Vedder, Luciana L. Almada, Andrey A. Yurchenko, Ismaël Padioleau, Bonnie Alver et al. · 2021 · Nature Communications
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms
Jürgen Thiele, Hans Michael Kvasnicka, Attilio Orazi, Umberto Gianelli, Naseema Gangat, Alessandro Maria Vannucchi, Tiziano Barbui, Daniel A. Arber, Ayalew Tefferi · 2022 · American Journal of Hematology
Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
Yeming Zhou, Guiqin Huang, Xiaoya Cai, Ying Liu, Bingxin Qian, Dengju Li · 2024 · Biomarker Research
Chronic Myeloid Leukemia
Elias Joseph Jabbour, Hagop M. Kantarjian · 2025 · JAMA
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients
Giacomo Coltro, Abhishek Avinash Mangaonkar, Terra L. Lasho, Christy M. Finke, Prateek A. Pophali, Ryan Michael Carr, Naseema Gangat, Moritz Binder, Animesh Dev Pardanani, Martín E. Fernández-Zapico et al. · 2019 · Leukemia
Relationship between clone metrics and clinical outcome in clonal cytopenia
Anna Gallì, Gabriele Todisco, Eulalia Catamo, Cinzia Felicita Sala, Chiara Elena, Sara Pozzi, Elisa B. Bono, Virginia Valeria Ferretti, Ettore Rizzo, Elisabetta Molteni et al. · 2021 · Blood
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
Nolwenn Lucas, Matthieu Duchmann, Philippe Rameau, Floriane Noël, Paula Michea, Véronique Saada, Olivier Kosmider, Gérard Pierron, Martín E. Fernández-Zapico, Matthew T. Howard et al. · 2019 · Leukemia
Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing
Wibowo Arindrarto, Daniel Borràs, Ruben A. L. de Groen, Redmar R. van den Berg, Irene J. Locher, Saskia A.M.E. van Diessen, Rosalie van der Holst, Edith D. van der Meijden, M. Willy Honders, Rick H. de Leeuw et al. · 2020 · Leukemia
Mutational landscape and clinical outcome of patients with de novo acute myeloid leukemia and rearrangements involving 11q23/ KMT2A
Marius Bill, Krzysztof Mrózek, Jessica Kohlschmidt, Ann‐Kathrin Eisfeld, Christopher James Walker, Deedra Nicolet, Dimitrios Papaioannou, James Stewart Blachly, Shelley J. Orwick, Andrew J. Carroll et al. · 2020 · Proceedings of the National Academy of Sciences
Structural variants drive context-dependent oncogene activation in cancer
Zhichao Xu, Dong-Sung Lee, Sahaana Chandran, Victoria T. Le, Rosalind Bump, Jean Yasis, Sofia Dallarda, Samantha Marcotte, Benjamin Clock, Nicholas K. Haghani et al. · 2022 · Nature
Characterization of Mast Cell Activation Syndrome
Afrin, Lawrence B., Self, Sally, Menk, Jeremiah, Lazarchick, John · 2017 · The American Journal of the Medical Sciences
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Shayda Hemmati, Tamanna Zohra Haque, Kira Gritsman · 2017 · Frontiers in Oncology
Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia
Elias Joseph Jabbour, Ching‐Hon Pui, Hagop M. Kantarjian · 2018 · JAMA Oncology
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study
Lisanne van Prooyen Schuurman, Erik A. Sistermans, Diane Van Opstal, Lidewij Henneman, Mireille N. Bekker, Caroline J. Bax, Mijntje J. Pieters, Katelijne Bouman, Sonja de Munnik, Nicolette S. den Hollander et al. · 2022 · The American Journal of Human Genetics
A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
Eric Padron, Amy Elizabeth Dezern, Marcio Andrade‐Campos, Kris Vaddi, Peggy Scherle, Qing Zhang, Yan Ma, Maria E. Balasis, Sara Tinsley, Hanadi Ramadan et al. · 2016 · Clinical Cancer Research
Polycythemia vera treatment algorithm 2018
Ayalew Tefferi, Alessandro Maria Vannucchi, Tiziano Barbui · 2018 · Blood Cancer Journal
U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions
Ayalew Tefferi, Christy M. Finke, Terra L. Lasho, Curtis A. Hanson, Rhett P. Ketterling, Naseema Gangat, Animesh Dev Pardanani · 2018 · Leukemia
Current challenges and unmet medical needs in myelodysplastic syndromes
Uwe Platzbecker, Anne Sophie Kubasch, Collin Homer-Bouthiette, Thomas Prébet · 2021 · Leukemia
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management
Mrinal M. Patnaik, Ayalew Tefferi · 2022 · American Journal of Hematology
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance
Hui Yang, Guillermo Garcia‐Manero, Koji Sasaki, Guillermo Montalban Bravo, Zhenya Tang, Yue Wei, Tapan Mahendra Kadia, Kelly Sharon Chien, Diana Marcela Rush, Nguyen Hong Ha et al. · 2022 · Leukemia
Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML
Akihide Yoshimi, Maria E. Balasis, Alexis Vedder, Kira Feldman, Yan Ma, Hailing Zhang, Stanley Chun-Wei Lee, Christopher T. Letson, Sandrine Niyongere, Sydney X. Lu et al. · 2017 · Blood
ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications
Peter Valent · 2018 · Pathobiology
Myeloproliferative neoplasms in the young: Mayo Clinic experience with 361 patients age 40 years or younger
Natasha Szuber, Rangit Reddy Vallapureddy, Domenico Penna, Terra L. Lasho, Christy M. Finke, Curtis A. Hanson, Rhett P. Ketterling, Animesh Dev Pardanani, Naseema Gangat, Ayalew Tefferi · 2018 · American Journal of Hematology
Genetic characterization of ABT-199 sensitivity in human AML
Richard Bisaillon, Céline Moison, Clarisse Thiollier, Jana Krošl, Marie-Ève Bordeleau, Bernhard Lehnertz, Vincent‐Philippe Lavallée, Tara MacRae, Nadine Mayotte, Caroline Labelle et al. · 2019 · Leukemia
Survival following allogeneic transplant in patients with myelofibrosis
Krisstina L. Gowin, Karen Kuhn Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy, Rebecca Devlin, Maria Frances Coakley, Aaron Thomas Gerds, Michael Green et al. · 2020 · Blood Advances
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult patients with AML
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C. Savage, Tiffany L. Lee, Jose M. Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina E. Tognon et al. · 2021 · Blood
Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial
Naval Guastad Daver, Monique Dail, Jacqueline Suen Garcia, Brian Andrew Jonas, Karen W L Yee, Kevin R. Kelly, Norbert Vey, Sarit E. Assouline, Gail J. Roboz, Stefania Paolini et al. · 2022 · Blood
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis
Celalettin Üstün, Jason R. Gotlib, Uday Popat, Andrew S. Artz, Mark Robert Litzow, Andreas Reiter, Ryotaro Nakamura, Hanneke C. Kluin‐Nelemans, Srđan Verstovšek, James Gajewski et al. · 2016 · Transplantation and Cellular Therapy
Presentation and outcomes among patients with isolated myeloid sarcoma: a Surveillance, Epidemiology, and End Results database analysis
Maryam Movassaghian, Andrew Mark Brunner, Traci M. Blonquist, Hossein Sadrzadeh, Ashmeet Bhatia, Ashley Marie Perry, Eyal C. Attar, Philip C. Amrein, Karen Kuhn Ballen, Donna S Neuberg et al. · 2014 · Leukemia & lymphoma/Leukemia and lymphoma
The clinical and molecular diversity of mast cell leukemia with or without associated hematologic neoplasm
Mohamad Jawhar, Juliana Schwaab, Manja Meggendorfer, Nicole Naumann, Hans‐Peter Horny, Karl Sotlar, Torsten Haferlach, Karla Schmitt, Alice Charlotte Fabarius, Peter Valent et al. · 2017 · Haematologica
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemia
A-K Eisfeld, Krzysztof Mrózek, Jessica Kohlschmidt, Deedra Nicolet, Shelley J. Orwick, Christopher James Walker, Karl W. Kroll, James Stewart Blachly, Andrew J. Carroll, Jonathan E. Kolitz et al. · 2017 · Leukemia
Epidemiology and survival of blastic plasmacytoid dendritic cell neoplasm
Guru Subramanian Guru Murthy, Naveen Pemmaraju, Ehab L. Atallah · 2018 · Leukemia Research
CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice
Amy Elizabeth Dezern, Luca Malcovati, Benjamin L. Ebert · 2019 · American Society of Clinical Oncology Educational Book
Leukemic Transformation in Myeloproliferative Neoplasms
Meera Yogarajah, Ayalew Tefferi · 2017 · Mayo Clinic Proceedings
An emerging trend of rapid increase of leukemia but not all cancers in the aging population in the United States
Taisen Hao, Min Li-Talley, Alison Buck, Wenyong Chen · 2019 · Scientific Reports
Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
Panagiotis Baliakas, Bianca Tesi, Ulla Wartiovaara‐Kautto, Asbjørg Stray‐Pedersen, Lone Smidstrup Friis, Ingunn Dybedal, Randi Hovland, Kirsi Jahnukainen, Klas Raaschou‐Jensen, Per T Ljungman et al. · 2019 · HemaSphere
Approach to the diagnosis of aplastic anemia
Amy Elizabeth Dezern, Jane E. Churpek · 2021 · Blood Advances
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology
Saverio D’Amico, Daniele Dall’Olio, Claudia Sala, Lorenzo Dall’Olio, Elisabetta Sauta, Matteo Zampini, Gianluca Asti, Luca Lanino, Giulia Maggioni, Alessia Campagna et al. · 2023 · JCO Clinical Cancer Informatics
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management
Mrinal M. Patnaik, Ayalew Tefferi · 2024 · American Journal of Hematology
MDS overlap disorders and diagnostic boundaries
Tiffany N. Tanaka, Rafael L. Bejar · 2019 · Blood
Platelet Counting: Ugly Traps and Good Advice. Proposals from the French-Speaking Cellular Hematology Group (GFHC)
Véronique Baccini, Franck Geneviève, Hugues Jacqmin, Bernard Châtelain, Sandrine Girard, Soraya Wuillème, Aurélie Védrenne, Eric Guiheneuf, Marie Toussaint‐Hacquard, Fanny Everaere et al. · 2020 · Journal of Clinical Medicine
Cytogenetics of Pediatric Acute Myeloid Leukemia: A Review of the Current Knowledge
Julie Quessada, Wendy Cuccuini, Paul Saultier, Marie Loosveld, Christine J. Harrison, Mårina Lafage‐Pochitaloff · 2021 · Genes
VEXAS Syndrome: A Case Series From a Single‐Center Cohort of Italian Patients With Vasculitis
Francesco Muratore, Chiara Marvisi, Paola Castrignanò, Davide Nicoli, Enrico Farnetti, Orsola Bonanno, Rosina Longo, Piera Zaldini, Elena Galli, Nicholas J. Balanda et al. · 2021 · Arthritis & Rheumatology
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia
Matteo Maria Naldini, Gabriele Casirati, Matteo Barcella, Paola M. V. Rancoita, Andrea Cosentino, Carolina Caserta, Francesca Pavesi, Erika Zonari, Giacomo Desantis, Diego Gilioli et al. · 2023 · Nature Communications
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes
Rafael Díaz de la Guardia, Belén López‐Millán, Jessie R. Lavoie, Clara Bueno, Julio Castaño, Maite Gómez-Casares, Susana Vives, Laura Palomo, Manel Juan, Julio Delgado et al. · 2017 · Stem Cell Reports
Acute myeloid leukaemia genomics
Michael Medinger, Jakob Robert Passweg · 2017 · British Journal of Haematology
Mutation patterns identify adult patients with de novo acute myeloid leukemia aged 60 years or older who respond favorably to standard chemotherapy: an analysis of Alliance studies
Ann‐Kathrin Eisfeld, Jessica Kohlschmidt, Krzysztof Mrózek, James Stewart Blachly, Christopher James Walker, Deedra Nicolet, Shelley J. Orwick, Sophia E. Maharry, Andrew J. Carroll, Richard Maury Stone et al. · 2018 · Leukemia
Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm
Polliana Mihaela Leru · 2019 · Clinical and Translational Allergy
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
Anna L Brown, Christopher Norman Hahn, Hamish S. Scott · 2020 · Blood
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies
Carmelo Gurnari, Simona Pagliuca, Lisa M. Durkin, Laila Terkawi, Hassan K. Awada, Sunisa Kongkiatkamon, Misam Zawit, Eric D. Hsi, Hetty E. Carraway, Heesun Joyce Rogers et al. · 2021 · Blood
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
Xingcheng Yang, Ling Ma, Xiaoying Zhang, Liang Huang, Jia Wei · 2022 · Experimental Hematology and Oncology
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages
Simone K. Feurstein, Amy M. Trottier, Noel Estrada‐Merly, Matthew J. Pozsgai, Kelsey E. McNeely, Michael William Drazer, Brian C. Ruhle, Katharine Sadera, Ashwin Lakshman Koppayi, Bart Lee Scott et al. · 2022 · Blood
Genomics of chronic neutrophilic leukemia
Julia E. Maxson, Jeffrey W Tyner · 2016 · Blood
NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML.
D. Sasca, Jakub Szybinski, A. Schüler, V. Shah, Jan B. Heidelberger, Patricia S. Haehnel, A. Dolnik, O. Kriege, Eva-Marie Fehr, W. Gebhardt et al. · 2019 · Blood
Circular RNAs of the nucleophosmin (NPM1) gene in acute myeloid leukemia
Susanne Lux, Tamara J. Blätte, Sarah Grasedieck, Sibylle Cocciardi, A. MAUREEN ROUHI, Mojca Jongen‐Lavrencic, Peter Paschka, Jan Krönke, Verena I. Gaidzik, Hartmut Döhner et al. · 2017 · Haematologica
PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia
Yuqing Dong, Yixiang Han, Yisha Huang, Songfu Jiang, Ziyang Huang, Rongrong Chen, Zhijie Yu, Yu Kang, Shenghui Zhang · 2020 · Frontiers in Immunology
Chronic myeloid leukemia-from the Philadelphia chromosome to specific target drugs: A literature review
Mariana Miranda Sampaio, Maria Luísa Cordeiro Santos, Hanna Santos Marques, Vinícius Lima de Souza Gonçalves, Glauber Rocha Lima Araújo, Luana Weber Lopes, Jonathan Santos Apolonio, Camilo Santana Silva, Luana Kauany de Sá Santos, Beatriz Rocha Cuzzuol et al. · 2021 · World Journal of Clinical Oncology
Structural racism is a mediator of disparities in acute myeloid leukemia outcomes
Ivy Elizabeth Abraham, Garth H. Rauscher, Anand Ashwin Patel, William B. Pearse, Priya Rajakumar, Madelyn Burkart, Ahmed Aleem, Ami Atulkumar Dave, Sushma Bharadwaj, Koosha Paydary et al. · 2022 · Blood
New oncogenic subtypes in pediatric B-cell precursor acute lymphoblastic leukemia
Henrik Lilljebjörn, Thoas Fioretos · 2017 · Blood
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
Hsin‐An Hou, Cheng‐Hong Tsai, Chien‐Chin Lin, Wen‐Chien Chou, Yuan‐Yeh Kuo, Chieh‐Yu Liu, Mei‐Hsuan Tseng, Yen‐Ling Peng, Ming-Chih Liu, Chia‐Wen Liu et al. · 2018 · Blood Cancer Journal
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm
Emily Y. Jen, Xin Gao, Liang Li, Luning Zhuang, Natalie E. Simpson, Baikuntha Aryal, Rong Wang, Donna Przepiorka, Yuan Li Shen, Ruby Leong et al. · 2019 · Clinical Cancer Research
Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia
Jifeng Yu, Yingmei Li, Tao Li, Yafei Li, Haizhou Xing, Hui Sun, Ling Sun, Dingming Wan, Yanfang Liu, Xinsheng Xie et al. · 2020 · Experimental Hematology and Oncology
Diagnosis and treatment of therapy-related acute myeloid leukemia
Stephen Anthony Strickland, Norbert Vey · 2022 · Critical Reviews in Oncology/Hematology
BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features
Nina Rosa Neuendorff, Thomas Burmeister, Bernd Dörken, Jörg Westermann · 2016 · Annals of Hematology
MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia
Stefania Trino, Daniela Lamorte, Antonella Caivano, Ilaria Laurenzana, Daniela Tagliaferri, Geppino Falco, Luigi Del Vecchio, Pellegrino Musto, Luciana De Luca · 2018 · International Journal of Molecular Sciences
Relapsed T Cell ALL: Current Approaches and New Directions
Christine M. McMahon, Selina M. Luger · 2019 · Current Hematologic Malignancy Reports
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML
Laura Simon, Jean-François Spinella, Chi‐Yuan Yao, Vincent‐Philippe Lavallée, Isabel Boivin, Geneviève Boucher, Eric Olivier Audemard, Marie-Ève Bordeleau, Sébastien Lemieux, Josée Hébert et al. · 2020 · Blood
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Hehlmann, Rüdiger, Voskanyan, Astghik, Lauseker, Michael, Pfirrmann, Markus, Kalmanti, Lida, Rinaldetti, Sebastien, Kohlbrenner, Katharina, Haferlach, Claudia, Schlegelberger, Brigitte, Fabarius, Alice et al. · 2020 · Leukemia
Identification of cell-type-specific mutations in nodal T-cell lymphomas
Tran Bich Nguyen, Mamiko Sakata‐Yanagimoto, Y Asabe, Daisuke Matsubara, Junko Kano, Kenichi Yoshida, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Satoru Miyano et al. · 2017 · Blood Cancer Journal
Myeloid neoplasms with germline DDX41 mutation
Jesse Cheah, Christopher Norman Hahn, Devendra Hiwase, Hamish S. Scott, Anna L Brown · 2017 · International Journal of Hematology
Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias
Shahzya Chaudhury, Caitríona O’Connor, Ana Cañete, Joana Bittencourt‐Silvestre, Evgenia Sarrou, Áine M. Prendergast, Jarny Choi, Pamela Johnston, Christine Anne Wells, Brenda E. S. Gibson et al. · 2018 · Nature Communications
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation
Philip Hollingsworth Imus, Amanda L. Blackford, Maria P. Bettinotti, Leo Luznik, Ephraim Joseph Fuchs, Carol Ann Huff, Douglas Edward Gladstone, Richard F. Ambinder, Ivan Borrello, Robert J. Fuchs et al. · 2019 · Transplantation and Cellular Therapy
Driver mutations in acute myeloid leukemia
Ashwin Kishtagari, Ross L. Levine, Aaron D. Viny · 2020 · Current Opinion in Hematology
Investigation and management of erythrocytosis
Siraj Mithoowani, Marissa Laureano, Mark Andrew Crowther, Christopher Hillis · 2020 · Canadian Medical Association Journal
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study
Guillermo Garcia‐Manero, Aaron D. Goldberg, Eric S. Winer, Jessica Kaplan Altman, Amir Tahmasb Fathi, Olatoyosi M. Odenike, Gail J. Roboz, Kendra Lynn Sweet, Crystal Miller, Anders Wennborg et al. · 2023 · The Lancet Haematology
Kidney Diseases Associated With Monoclonal Immunoglobulin M–Secreting B-Cell Lymphoproliferative Disorders: A Case Series of 35 Patients
Sophie Chauvet, Frank Bridoux, Laure Écotière, Vincent Javaugue, Christophe Sirac, Bertrand Arnulf, Antoine Thierry, Nathalie Quellard, Serge Milin, Sébastien Bender et al. · 2015 · American Journal of Kidney Diseases